NEURODEGENERATIVE DISEASES
Clinical trials for NEURODEGENERATIVE DISEASES explained in plain language.
Never miss a new study
Get alerted when new NEURODEGENERATIVE DISEASES trials appear
Sign up with your email to follow new studies for NEURODEGENERATIVE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stem cells take on Parkinson's: first safety trial begins
Disease control Not yet recruitingThis early-stage study tests whether a single treatment with human umbilical cord stem cells is safe and tolerable for people with Parkinson's disease. About 20 adults aged 18 to 75 will receive either stem cells or a placebo, and researchers will monitor side effects and any cha…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE1 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New PET tracer aims to spot brain diseases earlier
Diagnosis Not yet recruitingThis early-stage study will test a new imaging agent called 18F-FCOB04 in 40 people with neurodegenerative diseases like Alzheimer's or Parkinson's. The goal is to see if this PET scan tracer can safely highlight brain changes linked to these conditions and help with diagnosis. P…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 22, 2026 13:50 UTC
-
New VR and tablet tests aim to see what eye charts miss
Knowledge-focused Not yet recruitingThis study explores whether tablet and virtual reality tests can better capture the real-life vision problems people with neurodegenerative eye diseases face, like trouble recognizing faces or shopping. Fifty adults will try these new tools, and researchers will check if the resu…
Matched conditions: NEURODEGENERATIVE DISEASES
Sponsor: Nisha Nixon • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC